Clinical Trial: Clinical Efficacy of Intradermal Botulinum Toxin Type A in Erythematotelangiectatic Rosacea and Its Impact on Skin Microbiome: A Pilot Study (China)

China, Sept. 15 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Clinical Efficacy of Intradermal Botulinum Toxin Type A in Erythematotelangiectatic Rosacea and Its Impact on Skin Microbiome: A Pilot Study'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132393

Registration Time: 2026/09/14

Type: Interventional study

Primary Sponsor: Shandong Medical and Pharmaceutical University Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=343235

Published by HT Digital Content Services with permission from Health Daily Digest....